Arch Therapeutics, Inc. announced Dr. Avtar Dhillon as Board Chair, Dr. Arthur Rosenthal as Director, and Dr. Terrence W. Norchi as President & CEO. Dr. Dhillon has served as the Chairman of Board of Directors since April 2013 and has been on the Board of Directors of Arch Biosurgery, Inc. since May 2011. Previously, Dr. Dhillon was the President and Chief Executive Officer of Inovio Pharmaceuticals, Inc. Dr. Rosenthal was appointed a director of the company upon the consummation of the company's previously announced merger, and had been the Chairman of the Board of ABS since April 2011.

Dr. Norchi commenced service as President, Chief Executive Officer and a director on the company's Board of Directors on April 23, 2013. Dr. Norchi also served as the President, Chief Executive Officer and director of ABS since co-founding it in 2006.